In den Warenkorb
Bestellen Sie auch über:
![]() |
+49 (0)241 95 163 153 |
![]() |
+49 (0)241 95 163 155 |
SARS (Severe Acute Respiratory Syndrome) Spike Protein (0) Antikörper
| Antigen | SARS (Severe Acute Respiratory Syndrome) Spike Protein (0) |
| Klonalität | Polyklonal |
| Wirt |
Alternativen Kaninchen |
| Applikation |
Alternativen ELISA
|
![]() |
4 Publikationen vorhanden |
| Produktnummer | ABIN238099 |
| Menge | 100ug (1mg/ml) |
| Preis | 296,70 € Zzgl. Versandkosten €20,00 und MWSt |
| Lieferung nach |
|
| Verfügbarkeit | Lieferung in 5 bis 7 Werktagen |
Produktbeschreibung
| Weitere Bezeichnung | SARS (Severe Acute Respiratory Syndrome) Spike protein |
| Immunogen | Synthetic peptide corresponding to amino acids near the center of the SARS Spike glycoprotein (Genbank accession no. P59594). |
| Format | Affinity-purified, Liquid |
| Beschreibung | Rabbit A’ SARS Spike (Middle) Rabbit Antibody to SARS (Severe Acute Respiratory Syndrome) Spike protein |
| Spezifität | Reacts with the middle region of the spike protein of SARS-associated coronavirus. The spike protein is a glycosylated 139kDa protein and the major surface antigen of the virus. |
Anwendungen
| Applikationshinweise | Suitable for use in ELISA. It will detect 10ng of free peptide at 1ug/ml. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded. |
| Konzentration | 1mg/ml |
| Reinigung | Immunoaffinity chromatography |
| Buffer | PBS. Preservative: 0.02% Sodium Azide |
| Lagerung | Store (up to 1 year) at 2-8°C. : This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1-1.0%. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains. |
| Beschränkungen | Nur für Forschungszwecke einsetzbar |
Publikationen
| Publikationen |
Rota, Oberste, Monroe et al.: "Characterization of a novel coronavirus associated with severe acute respiratory syndrome." in: Science (New York, N.Y.), Vol. 300, Issue 5624, pp. 1394-9, 2003 (PubMed).
Marra, Jones, Astell et al.: "The Genome sequence of the SARS-associated coronavirus." in: Science (New York, N.Y.), Vol. 300, Issue 5624, pp. 1399-404, 2003 (PubMed). Li, Moore, Vasilieva et al.: "Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus." in: Nature, Vol. 426, Issue 6965, pp. 450-4, 2003 (PubMed). Navas-Martin, Weiss: "Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development." in: Journal of neurovirology, Vol. 10, Issue 2, pp. 75-85, 2004 (PubMed). |




Alternativen